Viewing Study NCT06528769


Ignite Creation Date: 2025-12-24 @ 11:07 PM
Ignite Modification Date: 2026-01-22 @ 1:49 PM
Study NCT ID: NCT06528769
Status: RECRUITING
Last Update Posted: 2025-09-30
First Post: 2024-07-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
Sponsor: Gabriel Tinoco
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module